share_log

Aclaris Therapeutics(ACRS.US) 10% Shareholder Buys US$628.21K in Common Stock

moomoo News ·  Jun 18 16:48

$Aclaris Therapeutics (ACRS.US)$ 10% Shareholder Leonard Braden Michael purchased 545K shares of common stock on Jun 14, 17, 18, 2024 at an average price of $1.1527 for a total value of $628.21K.

1718743711327137589.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment